GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Optimi Health Corp. Common Shares OPTH · USD

US listing · 🇺🇸 United States

Compare

2.50

+6.84%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Optimi Health Corp. Common Shares

Its shares trade under the ticker OPTH. It has been listed since 20 May 2026. In the fiscal year to 30 September 2025, it reported revenue of $302,148 and a net loss of $2.6m. At that date it held total assets of $10.8m and shareholders' equity of $4.7m.

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Listed since
20 May 2026
Head office
UNIT 600, 21 WATER STREET, VANCOUVER, A1, V6B 1A1
Incorporated in
A1
Classification
Pharmaceutical Preparations

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Optimi Health Corp. supplies MDMA and psilocybin to authorized clinics in Canada.
  • The company produces natural psilocybin and psilocin for health markets.
  • Optimi Health Corp. distributes mushroom supplements via Amazon marketplace.

Weaknesses

  • Optimi Health Corp. operates in a highly regulated pharmaceutical sector in Canada.
  • The company relies on Amazon marketplace for product distribution.
  • Optimi Health Corp. is based in Princeton, Canada, limiting local market access.

Opportunities

  • Expanding psychedelic drug supply to clinical trials in Canada.
  • Growing demand for mushroom supplements in health markets.
  • Increasing partnerships with authorized clinics in Canada.

Threats

  • Regulatory changes affecting controlled substances in Canada.
  • Competition from other pharmaceutical companies in Canada.
  • Potential supply chain disruptions for psychedelic substances.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.